PMID- 22118742 OWN - NLM STAT- MEDLINE DCOM- 20120531 LR - 20111128 IS - 1557-9832 (Electronic) IS - 0272-2712 (Linking) VI - 31 IP - 4 DP - 2011 Dec TI - Genetics of chronic lymphocytic leukemia. PG - 649-58, ix LID - 10.1016/j.cll.2011.07.006 [doi] AB - Morphology and the immunophenotype of chronic lymphocytic leukemia (CLL) are quite homogenous, but CLL's clinical course is not; some patients are stable for years, others experience rapid progression and poor response to chemotherapy. Fluorescence in situ hybridization (FISH) helped determine why these differences occur. Further progress has been made using comparative genomic hybridization and single nucleotide polymorphism (SNP) array analysis. Now the discovery of further dysregulated cellular pathways and potential new therapeutic targets is possible by genome-wide high-throughput next generation sequencing, which will likely also enter clinical diagnostics. FAU - Schnaiter, Andrea AU - Schnaiter A AD - Department of Internal Medicine III, University of Ulm, Albert Einstein Allee 23, 89081 Ulm, Germany. FAU - Mertens, Daniel AU - Mertens D FAU - Stilgenbauer, Stephan AU - Stilgenbauer S LA - eng PT - Journal Article PT - Review DEP - 20111117 PL - United States TA - Clin Lab Med JT - Clinics in laboratory medicine JID - 8100174 RN - 0 (Immunoglobulin Heavy Chains) SB - IM MH - Chromosome Aberrations MH - Comparative Genomic Hybridization MH - Humans MH - Immunoglobulin Heavy Chains/genetics MH - In Situ Hybridization, Fluorescence MH - Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis/*genetics MH - Prognosis MH - Survival Analysis EDAT- 2011/11/29 06:00 MHDA- 2012/06/01 06:00 CRDT- 2011/11/29 06:00 PHST- 2011/11/29 06:00 [entrez] PHST- 2011/11/29 06:00 [pubmed] PHST- 2012/06/01 06:00 [medline] AID - S0272-2712(11)00063-1 [pii] AID - 10.1016/j.cll.2011.07.006 [doi] PST - ppublish SO - Clin Lab Med. 2011 Dec;31(4):649-58, ix. doi: 10.1016/j.cll.2011.07.006. Epub 2011 Nov 17.